HESPERIDIN AS A PREVENTIVE RESISTANCE AGENT IN MCF-7 BREAST CANCER CELLS LINE RESISTANCE TO DOXORUBICIN
Abstract
To evaluate of hesperidin to overcome resistance of doxorubicin in MCF-7 resistant doxorubicin cells (MCF-7/Dox) in cytotoxicity apoptosis and P-glycoprotein (Pgp) expression in combination with doxorubicin